Fuan Pharmaceutical Group Co (300194): Kapitalflussrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 3,81 Renminbi Yuan | 4,935 Renminbi Yuan | 3,24 Renminbi Yuan |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - Renminbi Yuan | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 1.189.712.382 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 1.738.291,062 | 2.391.468,105 | 2.647.752,953 | 2.421.742,291 | 2.453.144,92 | 2.368.343,296 | 2.780.740,646 | 2.669.296,081 | 2.090.806,849 | 1.297.016,91 | 708.096,041 | 448.569,651 | 357.779,55 | 420.017,314 | 358.548,287 | 464.010,492 | 324.528,285 | 198.457,058 | 93.440,606 |
Cashflow aus operativer Geschäftstätigkeit | 312.324,659 | 303.586,355 | 328.978,127 | 339.498,85 | 257.128,839 | 162.552,887 | 295.627,587 | 267.675,482 | 453.370,24 | 374.162,616 | 161.026,698 | -31.268,073 | 89.610,166 | 62.766,741 | 64.851,076 | 105.743,38 | 62.747,733 | 49.226,873 | 18.916,523 |
▸ Operative Cashflow Marge | 17,97% | 12,69% | 12,42% | 14,02% | 10,48% | 6,86% | 10,63% | 10,03% | 21,68% | 28,85% | 22,74% | -6,97% | 25,05% | 14,94% | 18,09% | 22,79% | 19,34% | 24,8% | 20,24% |
Investitionsausgaben (CapEx) | 108.432,468 | 241.790,125 | 215.679,56 | 383.103,586 | 413.034,83 | 344.533,083 | 223.795,754 | 132.160,151 | 84.622,7 | 153.914,737 | 92.159,976 | 55.301,118 | 171.968,448 | 132.440,958 | 100.923,984 | 68.735,259 | 31.038,322 | 34.478,189 | 14.582,929 |
Cashflow aus Investitionstätigkeit | - | -264.834,618 | -93.621,808 | -440.005,836 | -349.239,023 | -316.836,967 | -274.962,582 | 12.669,558 | -236.420,605 | -890.865,863 | -581.323,963 | 23.702,068 | -262.286,198 | -149.494,515 | -206.368,7 | -72.905,259 | -34.047,134 | -42.317,138 | -17.113,709 |
Cashflow aus Finanzierungstätigkeit | - | -227.928,567 | 46.253,719 | -171.677,578 | 211.411,866 | 326.981,413 | 31.108,78 | -39.033,621 | -134.841,888 | 546.610,057 | -100.228,582 | -35.286,617 | -40.902,394 | -71.051,498 | 1.277.485,002 | -25.417,708 | -13.208,292 | 3.802,762 | 1.612,927 |
Freier Cashflow | 203.892,19 | 61.796,23 | 113.298,567 | -43.604,736 | -155.905,991 | -181.980,196 | 71.831,833 | 135.515,331 | 368.747,54 | 220.247,879 | 68.866,722 | -86.569,191 | -82.358,282 | -69.674,217 | -36.072,908 | 37.008,121 | 31.709,411 | 14.748,684 | 4.333,594 |
▸ Freie Cashflow Marge | 11,73% | 2,58% | 4,28% | -1,8% | -6,36% | -7,68% | 2,58% | 5,08% | 17,64% | 16,98% | 9,73% | -19,3% | -23,02% | -16,59% | -10,06% | 7,98% | 9,77% | 7,43% | 4,64% |
Ausgeschüttete Dividenden | -104.990,903 | -84.217,397 | -93.981,545 | -28.090,899 | -59.485,619 | -59.485,619 | -2.372,088 | -120.389,725 | -80.602,942 | -40.945,788 | -32.928,582 | -35.099,333 | -40.943,333 | -40.298,048 | -499,885 | -6.668,308 | -22.677,392 | -837,238 | -887,073 |
Neuausgabe und Rückkäufe von Stammaktien | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.